Incyte Corp. Company Profile (NASDAQ:INCY)

Analyst Ratings

Consensus Ratings for Incyte Corp. (NASDAQ:INCY) (?)
Ratings Breakdown: 1 Hold Rating(s), 18 Buy Rating(s)
Consensus Rating:Buy (Score: 2.95)
Consensus Price Target: $107.71 (24.65% upside)

Analysts' Ratings History for Incyte Corp. (NASDAQ:INCY)
Show:
DateFirmActionRatingPrice TargetActions
7/18/2016Leerink SwannReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/12/2016Royal Bank Of CanadaInitiated CoverageOutperform$105.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/29/2016Goldman Sachs Group Inc.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/15/2016JMP SecuritiesReiterated RatingOutperform$100.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/7/2016BMO Capital MarketsReiterated RatingBuy$91.00 -> $97.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/6/2016Brean CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2016Morgan StanleyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2016Oppenheimer Holdings Inc.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2016Jefferies GroupReiterated RatingBuy$88.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/3/2016Cowen and CompanyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/22/2016ArgusBoost Price TargetBuy$92.00 -> $135.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/12/2016Barclays PLCBoost Price TargetOverweight$25.00 -> $85.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2016Piper Jaffray Cos.Boost Price TargetOverweight$65.00 -> $125.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/31/2016Bank of America Corp.Reiterated RatingBuy$145.00 -> $87.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/28/2016JPMorgan Chase & Co.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/19/2016Credit Suisse Group AGInitiated CoverageOutperform$110.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/5/2016Raymond James Financial Inc.Initiated CoverageMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/19/2015UBS AGReiterated RatingBuy$130.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/6/2015Nomura Holdings Inc.Boost Price TargetBuy$126.00 -> $146.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/20/2015SunTrust Banks Inc.Boost Price TargetBuy$93.00 -> $120.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/23/2014 forward)

Earnings

Earnings History for Incyte Corp. (NASDAQ:INCY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/2/2016        
5/9/2016Q116$0.29$0.12$266.38 million$263.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/11/2016Q415$0.09$0.29$223.54 million$243.88 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2015Q315($0.41)($0.22)$179.30 million$187.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2015Q215($0.11)($0.05)$153.27 million$162.98 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2015Q115($0.06)($0.11)$155.21 million$159.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/12/2015Q414($0.09)($0.22)$138.37 million$106.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2014Q3($0.06)$0.33$149.92 million$198.15 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2014Q214$0.05($0.22)$140.72 million$99.58 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2014Q114($0.17)($0.21)$97.70 million$89.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/12/2014Q413($0.10)($0.15)$98.04 million$97.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/31/2013Q313($0.13)($0.14)$81.40 million$85.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/1/2013Q2 2013$0.08$0.05$114.34 million$101.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2013Q1 2013($0.18)($0.12)$68.16 million$71.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/14/2013Q4 2012($0.02)$0.14$92.03 million$113.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2012Q312($0.21)($0.17)$60.61 million$60.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/2/2012($0.02)$0.03ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/26/2012($0.48)($0.36)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/15/2012($0.40)($0.44)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2011($0.43)($0.42)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/28/2011($0.36)($0.41)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2011($0.32)($0.21)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/10/2011$0.19$0.26ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Incyte Corp. (NASDAQ:INCY)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$0.02$0.34$0.14
Q2 20163($0.05)$0.03$0.00
Q3 20164($0.15)($0.01)($0.08)
Q4 20164($0.12)($0.07)($0.10)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Incyte Corp. (NASDAQ:INCY)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Incyte Corp. (NASDAQ:INCY)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
3/17/2016Julian BakerDirectorBuy800,000$63.98$51,184,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2016Julian BakerDirectorBuy64,290$70.79$4,551,089.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/16/2016Julian BakerDirectorBuy887,165$69.87$61,986,218.55View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/12/2016Julian BakerDirectorBuy2,251,427$63.53$143,033,157.31View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/15/2016Paula J. SwainEVPSell13,531$76.96$1,041,345.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/6/2016Richard S. LevyEVPSell3,937$101.86$401,022.82View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/7/2015Richard S. LevyEVPSell3,937$106.18$418,030.66View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/18/2015Paul A. FriedmanDirectorSell225,000$113.83$25,611,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2015Eric H. SiegelEVPSell2,222$104.86$232,998.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/6/2015Richard S. LevyEVPSell3,936$116.51$458,583.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2015Yao WenqingEVPSell5,786$124.78$721,977.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/13/2015Eric H. SiegelEVPSell2,222$101.49$225,510.78View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/6/2015Richard S. LevyEVPSell3,937$122.29$481,455.73View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/21/2015Reid M. HuberEVPSell10,000$124.29$1,242,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/16/2015Eric H. SiegelEVPSell2,222$130.69$290,393.18View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/11/2015Richard S LevyEVPSell4,301$130.00$559,130.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/8/2015Richard S. LevyEVPSell3,937$118.90$468,109.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2015Eric H SiegelEVPSell2,222$107.69$239,287.18View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2015Richard S LevyEVPSell70,217$120.00$8,426,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/14/2015Eric H SiegelEVPSell2,222$113.61$252,441.42View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/6/2015Richard S LevyEVPSell3,937$107.00$421,259.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/23/2015James M DalyEVPSell11,691$108.24$1,265,433.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/19/2015Richard S LevyEVPSell20,000$108.13$2,162,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/12/2015Eric H SiegelEVPSell2,223$105.31$234,104.13View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/8/2015Richard S LevyEVPSell3,937$107.58$423,542.46View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/27/2015Paul A FriedmanDirectorSell196,751$107.23$21,097,609.73View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/22/2015Paul A FriedmanDirectorSell102,243$108.22$11,064,737.46View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2015Eric H SiegelEVPSell2,222$104.99$233,287.78View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/23/2015James M DalyEVPSell36,941$107.67$3,977,437.47View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/17/2015Yao WenqingEVPSell7,150$102.04$729,586.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/14/2015Eric H SiegelEVPSell2,222$98.72$219,355.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/13/2015Yao WenqingEVPSell23,000$95.18$2,189,140.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/7/2015Yao WenqingEVPSell20,031$90.13$1,805,394.03View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/30/2015Laurent ChardonnetVPSell113,776$93.64$10,653,984.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/30/2015Reid M HuberEVPSell34,263$93.66$3,209,072.58View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/12/2015Barry A ArikoDirectorSell80,000$89.27$7,141,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/12/2015Eric H SiegelEVPSell2,222$89.72$199,357.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2015Eric H SiegelEVPSell13,333$85.00$1,133,305.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2015James M DalyEVPSell11,112$82.19$913,295.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/17/2015Paula J SwainEVPSell17,500$76.90$1,345,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/26/2015Eric H SiegelEVPSell13,542$79.85$1,081,328.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/23/2015James M DalyEVPSell11,109$77.68$862,947.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/20/2015Paula J SwainEVPSell17,500$74.17$1,297,975.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/16/2015Richard S LevyEVPSell12,000$73.07$876,840.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/8/2015Eric H SiegelEVPSell15,626$75.00$1,171,950.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/6/2015Richard S LevyEVPSell25,000$71.84$1,796,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/5/2015Paula J SwainEVPSell17,500$73.90$1,293,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/23/2014James M DalyEVPSell11,113$74.43$827,140.59View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/2/2014Schutter Richard U DeChairmanSell50,000$74.89$3,744,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/6/2014Paul A FriedmanDirectorSell185,653$67.87$12,600,269.11View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/23/2014James M DalyEVPSell11,111$53.49$594,327.39View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/23/2014James M DalyEVPSell11,111$47.65$529,439.15View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/16/2014Richard S LevyEVPSell8,000$47.58$380,640.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/18/2014Richard S LevyEVPSell8,000$51.97$415,760.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/23/2014James M DalyEVPSell11,111$48.54$539,327.94View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/16/2014Richard S LevyEVPSell8,000$48.15$385,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/23/2014James M DalyEVPSell11,111$56.03$622,549.33View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2014Richard S LevyEVPSell8,000$53.88$431,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2014David C HastingsCFOSell200,000$52.73$10,546,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/23/2014James M DalyEVPSell11,111$48.48$538,661.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2014Richard LevyEVPSell8,000$50.68$405,440.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/2/2014Laurent ChardonnetVPSell34,000$51.55$1,752,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/23/2014James DalyEVPSell30,555$47.71$1,457,779.05View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/20/2014Paul FriedmanDirectorSell33,354$63.51$2,118,312.54View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/19/2014Paul FriedmanDirectorSell771,182$65.65$50,628,098.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/19/2014Schutter Richard DeChairmanSell50,000$65.53$3,276,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2014David HastingsCFOSell275,000$65.86$18,111,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2013Paul A FriedmanCEOSell376,789$37.32$14,061,765.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/9/2013Laurent ChardonnetVPSell44,834$37.31$1,672,756.54View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/6/2013David C HastingsCFOSell100,000$35.16$3,516,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/6/2013Richard S LevyEVPSell25,000$35.28$882,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/5/2013Paula J SwainEVPSell94,444$35.06$3,311,206.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2013Roy WhitfieldDirectorSell50,000$26.70$1,335,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/17/2013Roy A WhitfieldDirectorSell40,000$23.08$923,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2013Richard S LevyEVPSell55,699$22.30$1,242,087.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Incyte Corp. (NASDAQ:INCY)
DateHeadline
07/22/16 04:35 PMIncyte Corporation (NASDAQ:INCY): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/22/16 04:35 PMAttention Grasping Stock With Upward Momentum: Incyte Corporation (NASDAQ:INCY) - TGP
07/22/16 07:36 AMStock Catching Eyes of Investors: Incyte Corporation (NASDAQ:INCY) - TGP
07/22/16 07:36 AMLooking At Recent Analyst Ratings: Analog Devices, Inc. (NASDAQ:ADI), Incyte Corporation (NASDAQ:INCY) - Review Fortune
07/21/16 04:49 PMPeritoneal Cancer Market : Dynamics, Segments, Size and Demand to 2016 – 2022
07/21/16 04:49 PMIncyte Breaks Above 200-Day Moving Average - Bullish for INCY
07/21/16 06:08 AMEli Lilly (LLY) May Beat Q2 Earnings: Will the Stock Gain? -
07/20/16 07:39 AMStock Focus: Following Analyst Expectations on Shares of Incyte Corporation (NASDAQ:INCY) - TGP
07/20/16 07:39 AMForm 4 INCYTE CORP For: Jul 15 Filed by: Stein Steven H - StreetInsider.com
07/19/16 04:45 PMINCYTE CORP : Change in Directors or Principal Officers (form 8-K)
07/19/16 03:07 PMINCYTE CORP Files SEC form 8-K, Change in Directors or Principal Officers -
07/19/16 06:35 AMUpdated Data for Epacadostat, Incyte’s Selective IDO1 Inhibitor, Accepted for Presentation at the ESMO Annual Congress 2016 - [Business Wire] - Incyte Corporation announces that updated data from the Phase 1 portion of the ECHO-202/KEYNOTE-037 trial has been accepted for a poster discussion at the European Society for Medical Oncology Annual Congress 2016, taking place in Copenhagen, Denmark from October 7-11, 2016.
07/18/16 04:49 PMAnalyst Recommended Stock: Incyte Corporation (NASDAQ:INCY) - News Oracle
07/18/16 09:53 AMNew Broker Ratings For Incyte Corporation (NASDAQ:INCY) - FTSE News
07/18/16 09:53 AMShares of Incyte Corporation (INCY) Drops by -2.18% - Trade Calls
07/17/16 09:02 AMStrong Sell Calls For Incyte Corporation (NASDAQ:INCY) At 0 - Investor Newswire
07/16/16 08:01 AMRBC Capital Markets disclosed (NASDAQ:INCY) Incyte, increasing its target price to $105 earlier today
07/16/16 08:01 AMNasdaq 100 Movers: NCLH, INCY
07/15/16 03:42 PMBioMarin Pharmaceutical Inc versus Incyte Corporation Head to Head Compare - CML News
07/15/16 08:16 AMIncyte Corporation (NASDAQ:INCY)'s Growth Projection - RealistInvestor.com
07/15/16 08:16 AMIncyte Corporation Realized Volatility Hits Substantially Low Level - CML News
07/15/16 08:16 AMLarge Inflow of Money Detected in Incyte Corporation - TheFounders Daily
07/14/16 04:49 PMNasdaq 100 Movers: NXPI, CSX
07/14/16 08:09 AMU.S. stocks mixed, as Dow and S&P 500 remain near all-time record highs
07/14/16 07:38 AMIncyte to Report Second Quarter Financial Results - [at noodls] - WILMINGTON, Del.--(BUSINESS WIRE)--Jul. 14, 2016-- Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled its second quarter 2016 financial results conference call and webcast for 10:00 ...
07/13/16 07:33 AMWill Incyte Corporation (NASDAQ:INCY) Surprise Analysts? - Investor Newswire
07/11/16 09:19 AMStock Rating Watch and Earnings Insight for Incyte Corporation (NASDAQ:INCY) - Press Telegraph
07/10/16 04:12 PMIs $135 Within Reach For Incyte Corporation (NASDAQ:INCY)? - Investor Newswire
07/10/16 04:12 PMCan Incyte Corporation (NASDAQ:INCY) Meet Analysts Expectations? - Stocks Daily
07/08/16 07:32 AMIncyte Corporation Stock Momentum Hits Strength - CML News
07/08/16 07:32 AMPrevious Trading Session Wrap-Up: Incyte Corporation (NASDAQ:INCY) - Press Telegraph
07/08/16 07:32 AMShares of Incyte Corporation (INCY) Sees Large Outflow of Money - TheFounders Daily
07/07/16 04:44 PMIncyte corporation - product pipeline review report for 2016 published by leading research firm
07/07/16 08:15 AMBetter Buy: Alnylam Pharmaceuticals, Inc. vs. Incyte - Does Alnylam's RNA interference gamble make it a better buy than the purveyor of a single drug?
07/07/16 07:31 AMLeading stocks in today's market: Incyte Corporation (NASDAQ:INCY) - Twin County News
07/07/16 07:31 AMBb Biotech Ag Increased Incyte Corp. (NASDAQ:INCY) by $6.48 Million as Shares Declined - Press Telegraph
07/05/16 09:14 AMTake a look at Analysts Tips: Incyte Corporation (NASDAQ:INCY) , InspireMD, Inc. (NYSEMKT:NSPR) - Street Updates
07/05/16 09:14 AMIncyte Corporation (NASDAQ:INCY) Broker Price Targets For The Coming Week - Fiscal Standard
07/03/16 04:13 PMIncyte Corporation Product Pipeline Review 2016
07/02/16 04:30 PMShare Performance Recap for: Incyte Corporation (NASDAQ:INCY) - Press Telegraph
07/02/16 07:31 AMMedivation Inc, BioMarin Pharmaceutical Inc., Incyte Corporation: Next M&A Objectives - Business Finance News
07/02/16 07:31 AMGlobal Incyte Corporation Product Pipeline Review 2016 - Analysis, Technologies & Forecasts Report - Research and ... - Business Wire (press release)
07/02/16 07:31 AMIncyte Corporation Product Pipeline Review 2016 - Medgadget.com (blog)
07/01/16 04:38 PMGlobal Incyte Corporation Product Pipeline Review 2016 Analysis and Opportunities
07/01/16 03:06 PMINCYTE CORP Files SEC form 8-K/A, Financial Statements and Exhibits -
07/01/16 07:26 AMJun 30, 2016, 9:43am EDT - Philadelphia Business Journal (blog)
06/30/16 04:54 PMGlobal Incyte Corporation Product Pipeline Review 2016 - Analysis, Technologies & Forecasts Report - Research and Markets
06/30/16 07:31 AMAmgen, Incyte Well Positioned Following Brexit
06/29/16 04:35 PMArtal Group Sa Increased Incyte Corp (NASDAQ:INCY) by $39.60 Million as Shares Declined - Engelwood Daily
06/28/16 04:33 PMNew report examines the non-hodgkin lymphoma pipeline landscape and therapeutics under development market review 2016

Social

About Incyte Corp.

Incyte Corp. logoIncyte Corporation is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutics to treat medical needs, primarily in oncology. The Company focuses on the research and development program to explore the inhibition of enzymes called janus associated kinases (JAK). The Company's pipeline includes compounds in various stages, ranging from preclinical to late stage development, and a commercialized product, JAKAFI (ruxolitinib). The Company has discovered multiple potent, selective and orally bioavailable JAK inhibitors that are selective for JAK1 or JAK1 and JAK2. JAKAFI is the compound in its JAK program, which is an oral JAK1 and JAK2 inhibitor. JAKAFI orphan drug is indicated for Myelofibrosis (MF), Polycythemia Vera (PV) and essential thrombocythemia. The Company's second oral JAK1 and JAK2 inhibitor is baricitinib.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: INCY
  • CUSIP: 45337C10
Key Metrics:
  • Previous Close: $87.79
  • 50 Day Moving Average: $81.55
  • 200 Day Moving Average: $76.76
  • P/E Ratio: 348.43
  • P/E Growth: 44.66
  • Market Cap: $16.21B
  • Beta: 0.77
  • Current Year EPS Consensus Estimate: $-0.01 EPS
  • Next Year EPS Consensus Estimate: $1.36 EPS
Additional Links:
Incyte Corp. (NASDAQ:INCY) Chart for Saturday, July, 23, 2016